Decis® forte Deutschland - Deutsch - BVL (Bundesamt für Verbraucherschutz und Lebensmittelsicherheit)

decis® forte

bayer ag - 100 g/l deltamethrin - emulsionskonzentrat - 100 g/l deltamethrin - insektizid

Fandango® Deutschland - Deutsch - BVL (Bundesamt für Verbraucherschutz und Lebensmittelsicherheit)

fandango®

bayer ag - 100 g/l fluoxastrobin; 100 g/l prothioconazol - emulsionskonzentrat - 100 g/l prothioconazol; 100 g/l fluoxastrobin - fungizid

Infinito® Deutschland - Deutsch - BVL (Bundesamt für Verbraucherschutz und Lebensmittelsicherheit)

infinito®

bayer ag - 523,8 g/l propamocarb (625 g/l hydrochlorid); 62,5 g/l fluopicolide - suspensionskonzentrat - 62,5 g/l fluopicolide; 625,0 g/l propamocarb-hcl - top

Laudis® Plus (Laudis® + Delion®) Deutschland - Deutsch - BVL (Bundesamt für Verbraucherschutz und Lebensmittelsicherheit)

laudis® plus (laudis® + delion®)

bayer ag - 44 g/l tembotrione - Ölige dispersion - 44 g/l tembotrione; 22 g/l isoxadifen-ethyl (safener); 480 g/l dicamba ((577,9 g/l dimethylamin-salz)) - top

Proline® Deutschland - Deutsch - BVL (Bundesamt für Verbraucherschutz und Lebensmittelsicherheit)

proline®

bayer ag - 250 g/l prothioconazol - emulsionskonzentrat - 250 g/l prothioconazol - fungizid

Flebogamma DIF (previously Flebogammadif) Europäische Union - Deutsch - EMA (European Medicines Agency)

flebogamma dif (previously flebogammadif)

instituto grifols s.a. - human normal immunoglobulin - mucocutaneous lymph node syndrome; guillain-barre syndrome; bone marrow transplantation; purpura, thrombocytopenic, idiopathic; immunologic deficiency syndromes - immunseren und immunglobuline, - replacement therapy in adults, children and adolescents (0-18 years) in: , primary immunodeficiency syndromes with impaired antibody production;, hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic luekaemia, in whom prophylactic antibiotics have failed;, hypogammaglobulinaemia and recurrent bacterial infections in plateau-phase-multiple-myeloma patients who failed to respond to pneumococcal immunisation;, hypogammaglobulinaemia in patients after allogenic haematopoietic-stem-cell transplantation (hsct);, congenital aids with recurrent bacterial infections. , immunomodulation in adults, children and adolescents (0-18 years) in: , primary immune thrombocytopenia (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count;, guillain barré syndrome;, kawasaki disease.